CION Ameerpet
There is no single lymphoma growth rate. Aggressive lymphomas can grow over days to weeks; indolent ones change slowly over months or years. This guide explains what drives the speed — and why fast-growing is not the same as worse.
There is no single lymphoma growth rate — it depends almost entirely on the subtype. Lymphomas are broadly split into two groups. Aggressive (high-grade) lymphomas divide rapidly and can grow noticeably over days to a few weeks. Indolent (low-grade) lymphomas grow slowly and may barely change over months or even years. This is why two people with "lymphoma" can have completely different experiences.
The reassuring twist is that fast-growing does not mean worse. Because aggressive lymphoma cells divide quickly, they are often very sensitive to chemotherapy, and many aggressive lymphomas are curable. Slow-growing lymphomas are rarely cured outright but can be controlled for many years, and some are safely monitored before any treatment begins. Understanding the difference between fast vs slow lymphoma is the first step to understanding your own diagnosis.
For the full picture, start with our Lymphoma hub, or if you have a confirmed diagnosis, see Lymphoma Treatment in Hyderabad. You can also learn how common lymphoma is and how it spreads through the body.
Some aggressive lymphomas are among the fastest-growing human cancers — Burkitt lymphoma, for example, can double its volume in around 24–48 hours. Yet, precisely because its cells divide so rapidly, it is also one of the most chemotherapy-sensitive lymphomas, and a large proportion of patients can be cured with prompt, intensive treatment. Speed of growth and chances of cure are not the same thing. (Source: NCCN and ESMO B-cell lymphoma guidelines.)
Lymphomas are grouped by how quickly the cells divide. The table below shows the broad pattern — but your exact subtype, confirmed on biopsy, is what really guides the plan.
| Feature | Aggressive (high-grade) | Indolent (low-grade) |
|---|---|---|
| Growth speed | Days to weeks | Months to years |
| How it shows up | Rapidly enlarging node, fevers, night sweats, weight loss | Slowly enlarging node; often few or no symptoms |
| Ki-67 proliferation marker | High | Low |
| Usual approach | Prompt treatment, often chemotherapy-based | Treat, or actively monitor if symptom-free |
| Curability | Often curable | Very treatable; controlled long-term, rarely cured outright |
This is a general guide; growth patterns and outcomes vary by individual. The subtype and growth rate are decided by a pathologist on biopsy tissue, not by a scan or symptoms alone. Grouping follows NCCN and ESMO classifications.
Because "how fast does lymphoma grow" has such a wide range of answers, the value is in an accurate, individual assessment — not a generic figure.
Your growth rate is read from the biopsy tissue, including the Ki-67 proliferation index and markers such as MYC and BCL2. CION arranges expert haematopathology review so the subtype — and therefore the likely speed — is pinned down accurately.
A PET-CT scan shows how metabolically active the lymphoma is and how far it has spread. Where needed, a bone-marrow examination is done directly at CION. Together these define both speed and stage.
Every case is reviewed by a multidisciplinary tumour board, so the plan — prompt treatment versus careful monitoring — matches your subtype, symptoms and scans, in line with NCCN and ESMO guidance.
Chemotherapy, antibody-based immunotherapy, targeted therapy and radiation (IMRT) are delivered directly by CION. Stem-cell transplant and CAR-T, when needed, are coordinated through accredited partner facilities.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
A rapidly changing lump or new symptoms deserve a prompt, expert answer. CION's lymphoma team can review your reports and explain exactly what your subtype and growth rate mean.
The speed at which a lymphoma grows is written into the biology of its cells. Several factors, read from the biopsy and scans, tell the team where a particular lymphoma sits on the fast-to-slow spectrum:
This is why symptoms and scans alone cannot tell you the growth rate — a tissue biopsy with expert pathology is essential. If you are still awaiting a diagnosis, understanding whether a blood test can detect lymphoma and at what age lymphoma tends to occur can help you have a more informed conversation with your doctor.
Aggressive lymphomas, such as diffuse large B-cell lymphoma, grow over weeks and usually announce themselves with a rapidly enlarging node and symptoms like fevers, drenching night sweats or weight loss. Because they divide so fast, they respond strongly to chemotherapy combined with anti-CD20 antibody immunotherapy, and a substantial proportion are cured. Prompt treatment matters — these are the lymphomas where waiting is not advised. If you have been told your lymphoma is at an advanced stage, our page on whether stage 4 lymphoma is curable puts that in context.
Indolent lymphomas, such as follicular lymphoma, grow slowly and may cause few problems for a long time. Many people live well with them for years. Treatment is highly effective at controlling the disease, and for symptom-free cases the safest option can be active monitoring rather than immediate treatment. Read more about the day-to-day reality of living with an indolent (slow-growing) lymphoma and what life-expectancy figures actually mean.
Occasionally an indolent lymphoma can transform into a more aggressive type. This is one reason regular follow-up matters even when a lymphoma is stable — a change can be caught early. Any new, rapid growth or fresh symptoms during monitoring should prompt a prompt review and, if needed, a repeat biopsy.
For some slow-growing lymphomas that cause no symptoms, doing nothing straight away is an evidence-based choice. Active monitoring — often called watch-and-wait — is recommended in NCCN and ESMO guidelines for selected indolent lymphomas, and studies show that delaying treatment until it is actually needed does not shorten survival. It spares people the side effects of treatment while the disease is stable. (Source: NCCN B-cell lymphoma and ESMO follicular lymphoma guidelines.)
It is natural to assume a faster-growing cancer is more dangerous, but with lymphoma the relationship is not that simple. Growth speed guides how quickly treatment should start and which approach fits, but the outlook depends on many factors together — subtype, stage, molecular markers, age and overall health.
Published series report encouraging survival figures. Classical Hodgkin lymphoma has long-term survival of roughly 80–90%, and diffuse large B-cell lymphoma — an aggressive, fast-growing type — has around 60–70% survival, though these numbers vary considerably by individual and by stage at diagnosis (per NCCN and ESMO data). Indolent lymphomas are rarely cured outright but are typically controlled over many years. The key point: a fast-growing lymphoma can carry an excellent chance of cure, and a slow-growing one can be lived with for a long time.
The number of treatment sessions also depends on the subtype and stage — our page on how many cycles of chemotherapy you may need explains what to expect. And if you are worried about whether lymphoma is life-threatening, see is lymphoma a terminal illness?. For confirmed cases, our Lymphoma Treatment in Hyderabad page covers regimens and options in detail.
Because growth rate varies so much, timing questions come up often. It is worth seeking prompt expert review in these situations:
CION offers a dedicated, free written second-opinion service. You can also compare our best lymphoma doctors in Hyderabad and see why families choose our lymphoma hospital in Hyderabad. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if your subtype or Ki-67 proliferation result is unclear.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.There is no single answer — lymphoma growth rate depends entirely on the subtype. Aggressive (high-grade) lymphomas can double in size over days to a few weeks, so a lump or symptoms may appear and worsen quickly. Indolent (low-grade) lymphomas grow very slowly, sometimes changing little over months or years. Under a microscope, doctors estimate speed using a proliferation marker called Ki-67, which reflects the fraction of cells actively dividing. Because the difference between fast and slow lymphoma is so wide, the only reliable way to know how fast a particular lymphoma is growing is a biopsy and expert pathology review, guided by NCCN and ESMO criteria.
Lymphomas are broadly grouped as aggressive (high-grade) or indolent (low-grade). Aggressive lymphomas grow rapidly and cause noticeable symptoms — enlarging lymph nodes, fevers, night sweats or weight loss — over weeks. Paradoxically, because they divide quickly, many aggressive lymphomas respond very well to chemotherapy and a meaningful proportion are curable. Indolent lymphomas grow slowly and may cause few symptoms for a long time; they are highly treatable and controllable but are often not curable in the same sense, and some are safely monitored before treatment. Neither pattern is automatically "better" — each has its own treatment logic. Learn more about living with an indolent lymphoma.
A lymph node that enlarges quickly can be lymphoma, but it can also be a reaction to infection, which is far more common. Reactive nodes from a sore throat, dental infection or viral illness often swell over a few days, are tender, and settle within two to four weeks. A node that keeps growing, is painless and firm, sits above the collarbone, or comes with unexplained fevers, drenching night sweats or weight loss is more concerning and should be assessed. If a node has not resolved after three to four weeks, ask about a specialist review and, if needed, a biopsy. See also is lymphoma painful? for how the swelling typically feels.
Growth rate is assessed mainly on the biopsy tissue rather than from a scan alone. Pathologists examine how the cells look and use a marker called Ki-67 (also written MIB-1) to estimate the proportion of cells actively dividing — a low percentage suggests an indolent lymphoma, a high percentage suggests an aggressive one. Additional markers such as MYC and BCL2 can flag especially fast-behaving tumours. A PET-CT scan then shows how metabolically active the disease is across the body and how far it has spread. Together these give the team an accurate picture of speed and stage, following NCCN and ESMO pathology standards.
Not necessarily — this is one of the most reassuring facts about lymphoma. Because aggressive lymphomas divide quickly, their cells are often very sensitive to chemotherapy, and many are curable. Published series report that classical Hodgkin lymphoma has roughly 80–90% long-term survival and that diffuse large B-cell lymphoma, an aggressive type, has around 60–70% survival, though figures vary widely by stage, age and individual factors. Slow-growing lymphomas are rarely "cured" but can be controlled for many years. The speed of growth is only one factor; stage, subtype, molecular markers and overall health all matter. See what the survival numbers actually mean for context.
Lymphoma often starts in one group of lymph nodes and can travel through the connected lymphatic system to other node groups, the spleen, bone marrow or, less often, organs outside the lymph system. Aggressive lymphomas can spread over weeks, while indolent lymphomas may be widespread yet stable for a long time — so being at a higher stage does not always mean a worse outcome for slow-growing disease. Staging is done with a PET-CT and sometimes a bone-marrow examination, which CION performs directly. Read more about how lymphoma spreads through the body.
Not always. For some slow-growing (indolent) lymphomas that are not causing symptoms, the safest, evidence-based approach can be active monitoring — often called watch-and-wait — where the team keeps a close eye on the disease and starts treatment only if it progresses or causes problems. This is recommended in NCCN and ESMO guidelines and avoids unnecessary side effects while the lymphoma is stable. Aggressive lymphomas, by contrast, usually need prompt treatment. At CION, the decision is made by a multidisciplinary tumour board based on your subtype, symptoms and scans. A free second opinion can help you understand which path applies to you.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.